How to Free Your Data From Isolation: Learn Why Biopharma Leaders are Investing in the Cloud

Dr. Daniela Jansen is VP of Scientific Product Marketing at TetraScience. She has held various positions in marketing, sales and business development, including at Dassault Systèmes BIOVIA, Waters and Bio-Rad Laboratories. Daniela has a long tenure of expertise in life sciences, laboratory and scientific informatics as well as in quality and regulatory compliance. Today she is responsible for the strategic messaging and positioning of TetraScience’s scientific products and applications, the development of marketing content with a strong focus on customer value and industry needs.

Ken began his career as a chemist at Waters Corporation in 2001, where he developed analytical methods for oligonucleotide, peptide, and protein analysis. In 2004, he moved to Genzyme Corporation (now Sanofi Genzyme), where he implemented UPLC for the analysis of small molecules. Ken returned to Waters in 2007, where he managed the Chemistry Applied Technology and Technology Advancement groups, both of which focused on development and application of consumables for the pharmaceutical, biopharmaceutical, and food and environmental markets. Ken also served as Director of the Biopharmaceutical Business, Senior Director of Scientific Operations, and Senior Director of Global Products responsible for new LC technology development at Waters.  Before joining Tetrascience, Ken was a Senior Research Fellow at Vertex Pharmaceuticals in Boston, Massachusetts, where he led all analytical development activities for the next generation cystic fibrosis potentiator (VX-561), as well as all analytical HPLC method development efforts for small molecule drug assets in the acute and chronic pain disease area.  Today, Ken and his team develop use case accelerators to help pharmaceutical and biotechnology companies replatform their R&D data to the cloud.